Laura Faiver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Laura Faiver has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Jonathan Elmer
Department of Critical Care Medicine, University of Pittsburgh School of Medicine; Department of Emergency Medicine, University of Pittsburgh School of Medicine; Department of Neurology, University of Pittsburgh School of Medicine
3 shared publicationsPatrick J. Coppler
Department of Emergency Medicine, University of Pittsburgh School of Medicine
3 shared publicationsByron C. Drumheller
2 shared publicationsCecelia R. Ratay
Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 shared publicationsJonathan Tam
Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA, 15213, USA
2 shared publications- Andrew M. Nguyen
University of Chicago, Chicago, IL
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in Resuscitation
- p. 111360
Association between burst-suppression with identical bursts and multimodal measures of cerebral oxygenation after cardiac arrest
- 20 October 2026
- Published by Elsevier in Resuscitation
- p. 111360
Open AccessAssociation between burst-suppression with identical bursts and multimodal measures of cerebral oxygenation after cardiac arrest
- 27 May 2026
- Published by Springer Nature in Neurocritical Care
- Vol. 45 (2) , 813-822
Intracranial Pressure and Brain Tissue Oxygen Trajectories after Cardiac Arrest
Brain tissue hypoxia [brain tissue oxygen tension (PbtO2) < 20 mm Hg] and elevated intracranial pressure (ICP) ≥ 22 mm Hg exacerbate hypoxic-ischemic brain injury (HIBI) after cardiac arrest. Multiple pathophysiologic derangements can cause brain tissue hypoxia and/or elevated ICP with impaired intracranial compliance. The mechanisms and severity of these pathophysiologic changes vary both between patients and within patients over time. Clinically distinct phenotypes of HIBI may have different trajectories of PbtO2 and ICP. We conducted a single-center retrospective study of patients who survived until hospitalization after cardiac arrest and underwent invasive neuromonitoring. We used group-based trajectory modeling to identify distinct trajectories of PbtO2 and ICP separately over the first 72 h post-arrest and described the clinical characteristics of each trajectory group. We included 43 patients who underwent invasive neuromonitoring. We identified three ICP trajectory groups. Group 1 was characterized by normal ICP throughout monitoring, while group 2 demonstrated High-normal ICP during the study period. Group 3 had initially normal ICP, which rapidly increased and remained pathologically elevated thereafter. All ICP trajectory groups had episodically abnormal ICP, PbtO2, and cerebral perfusion pressure (CPP) during monitoring. We identified three PbtO2 trajectory groups. Group 1 had persistent brain tissue hypoxia with more pathological elevations in ICP and inadequate CPP than the other PbtO2 trajectory groups. Group 2 had mostly normal PbtO2, while PbtO2 in group 3 increased linearly over 72 h, though there was a comparable incidence of brain tissue hypoxia, elevated ICP, and low CPP. However, PbtO2 group 3 had lower survival and more frequently exhibited evidence of severe HIBI. We identified distinct PbtO2 and ICP trajectories after cardiac arrest. Our findings suggest that the physiology of hypoxic-ischemic brain injury is variable, and trajectory groups may represent distinct phenotypes. This work provides a foundation for future studies aimed at disentangling the heterogeneity of hypoxic-ischemic brain injury.
- 27 May 2026
- Published by Springer Nature in Neurocritical Care
- Vol. 45 (2) , 813-822
Intracranial Pressure and Brain Tissue Oxygen Trajectories after Cardiac Arrest
Brain tissue hypoxia [brain tissue oxygen tension (PbtO2) < 20 mm Hg] and elevated intracranial pressure (ICP) ≥ 22 mm Hg exacerbate hypoxic-ischemic brain injury (HIBI) after cardiac arrest. Multiple pathophysiologic derangements can cause brain tissue hypoxia and/or elevated ICP with impaired intracranial compliance. The mechanisms and severity of these pathophysiologic changes vary both between patients and within patients over time. Clinically distinct phenotypes of HIBI may have different trajectories of PbtO2 and ICP. We conducted a single-center retrospective study of patients who survived until hospitalization after cardiac arrest and underwent invasive neuromonitoring. We used group-based trajectory modeling to identify distinct trajectories of PbtO2 and ICP separately over the first 72 h post-arrest and described the clinical characteristics of each trajectory group. We included 43 patients who underwent invasive neuromonitoring. We identified three ICP trajectory groups. Group 1 was characterized by normal ICP throughout monitoring, while group 2 demonstrated High-normal ICP during the study period. Group 3 had initially normal ICP, which rapidly increased and remained pathologically elevated thereafter. All ICP trajectory groups had episodically abnormal ICP, PbtO2, and cerebral perfusion pressure (CPP) during monitoring. We identified three PbtO2 trajectory groups. Group 1 had persistent brain tissue hypoxia with more pathological elevations in ICP and inadequate CPP than the other PbtO2 trajectory groups. Group 2 had mostly normal PbtO2, while PbtO2 in group 3 increased linearly over 72 h, though there was a comparable incidence of brain tissue hypoxia, elevated ICP, and low CPP. However, PbtO2 group 3 had lower survival and more frequently exhibited evidence of severe HIBI. We identified distinct PbtO2 and ICP trajectories after cardiac arrest. Our findings suggest that the physiology of hypoxic-ischemic brain injury is variable, and trajectory groups may represent distinct phenotypes. This work provides a foundation for future studies aimed at disentangling the heterogeneity of hypoxic-ischemic brain injury.
- Open Access
- 7 November 2024
- Published by Elsevier in Resuscitation
- Vol. 222, 110429
Association of hyperosmolar therapy with cerebral oxygen extraction after cardiac arrest
- 7 November 2024
- Published by Elsevier in Resuscitation
- Vol. 222, 110429
Open AccessAssociation of hyperosmolar therapy with cerebral oxygen extraction after cardiac arrest
- Open Access
- 24 August 2021
- Published by SAGE Publications in The Neurohospitalist
- Vol. 12 (1) , 31-37
Incidence, Predictors and Outcomes of Delirium in Critically Ill Patients With COVID-19
Background and Purpose: A variety of neurological manifestations have been attributed to COVID-19, but there is currently limited evidence regarding risk factors and outcomes for delirium in critically ill patients with COVID-19. The purpose of this study was to identify delirium in a large cohort of ICU patients with COVID-19, and to identify associated features and clinical outcomes at the time of hospital discharge. Methods: This is an observational cohort study of 213 consecutive patients admitted to an ICU for COVID-19 respiratory illness. Delirium was diagnosed by trained abstractors using the CHART-DEL instrument. The associations between key clinical features, sedation and delirium were examined, as were the impacts of delirium on clinical outcomes. Results: Delirium was identified in 57.3% of subjects. Delirious patients were more likely to receive mechanical ventilation, had lower P: F ratios, higher rates of renal replacement therapy and ECMO, and were more likely to receive enteral benzodiazepines. Only mechanical ventilation remained a significant predictor of delirium in a logistic regression model. Mortality was not significantly different, but delirious patients experienced greater mechanical ventilation duration, ICU/hospital lengths of stay, worse functional outcomes at discharge, and were less likely to be discharged home. Conclusions: Delirium is common in critically ill patients with COVID-19 and appears to be associated with greater disease severity. When present, delirium is associated with worse functional status at discharge, but not increased mortality. Additional studies are necessary to determine the generalizability of these results and the impact of delirium on longer-term cognitive and functional outcomes.
- 24 August 2021
- Published by SAGE Publications in The Neurohospitalist
- Vol. 12 (1) , 31-37
Open AccessIncidence, Predictors and Outcomes of Delirium in Critically Ill Patients With COVID-19
Background and Purpose: A variety of neurological manifestations have been attributed to COVID-19, but there is currently limited evidence regarding risk factors and outcomes for delirium in critically ill patients with COVID-19. The purpose of this study was to identify delirium in a large cohort of ICU patients with COVID-19, and to identify associated features and clinical outcomes at the time of hospital discharge. Methods: This is an observational cohort study of 213 consecutive patients admitted to an ICU for COVID-19 respiratory illness. Delirium was diagnosed by trained abstractors using the CHART-DEL instrument. The associations between key clinical features, sedation and delirium were examined, as were the impacts of delirium on clinical outcomes. Results: Delirium was identified in 57.3% of subjects. Delirious patients were more likely to receive mechanical ventilation, had lower P: F ratios, higher rates of renal replacement therapy and ECMO, and were more likely to receive enteral benzodiazepines. Only mechanical ventilation remained a significant predictor of delirium in a logistic regression model. Mortality was not significantly different, but delirious patients experienced greater mechanical ventilation duration, ICU/hospital lengths of stay, worse functional outcomes at discharge, and were less likely to be discharged home. Conclusions: Delirium is common in critically ill patients with COVID-19 and appears to be associated with greater disease severity. When present, delirium is associated with worse functional status at discharge, but not increased mortality. Additional studies are necessary to determine the generalizability of these results and the impact of delirium on longer-term cognitive and functional outcomes.